Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM

NCT04267601 · clinicaltrials.gov ↗

UNKNOWN

Status

2448

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Anagliptin

Sponsor

JW Pharmaceutical